Health In Tech Announces Fourth Quarter and Full Year 2025 Financial Results

Rhea-AI Summary

Health In Tech (NASDAQ: HIT) reported full-year 2025 revenue of $33.3 million (up 71% YoY) and adjusted EBITDA of $4.1 million (up 81% YoY). Net income for 2025 was $1.3 million (up 91% YoY). Q4 2025 revenue was $7.5 million (up 53% YoY) and billed enrolled employees totaled 22,515 as of December 31, 2025.

The company projects 2026 revenue of $45–$50 million (approx. 35%–50% growth), highlighted platform feature launches, expanded distribution, and a cash balance of $7.7 million as of year-end.

Positive

• Revenue +71% YoY to $33.3 million
• Adjusted EBITDA +81% YoY to $4.1 million
• Net income +91% YoY to $1.3 million
• Billed employees +23% YoY to 22,515

Negative

• Q4 adjusted EBITDA down from $0.5M to $0.3M
• Q4 net loss of $0.3 million versus prior-year $0.1 million

News Market Reaction – HIT

-11.05%

11 alerts

-11.05% Session close to close

+2.6% Peak Tracked

-25.3% Trough Tracked

$113.92M Market Cap

0.4x Rel. Volume

In the Mar 26 session, HIT declined 11.05%, reflecting a significant negative market reaction. Argus tracked a peak move of +2.6% during that session. Argus tracked a trough of -25.3% from its starting point during tracking. Our momentum scanner triggered 11 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock dropped -11.1% in the session following this news. A negative reaction despite strong full...

Analysis

The stock dropped -11.1% in the session following this news. A negative reaction despite strong full-year growth would fit prior patterns, where average earnings-day moves were -4.38% and Q3 2025 drew a steep decline despite positive numbers. Investors may focus on Q4 margin softness and net loss, testing confidence in the $45–$50 million 2026 revenue outlook and the company’s ability to translate rapid top-line growth into consistent profitability.

Key Figures

FY 2025 revenue: $33.3 million Q4 2025 revenue: $7.5 million FY 2025 Adjusted EBITDA: $4.1 million +5 more

8 metrics

FY 2025 revenue $33.3 million Full year 2025, up 71% YoY

Q4 2025 revenue $7.5 million Q4 2025, up 53% YoY

FY 2025 Adjusted EBITDA $4.1 million Full year 2025, up 81% YoY

Q4 2025 Adjusted EBITDA $0.3 million Q4 2025 vs $0.5 million prior-year Q4

FY 2025 net income $1.3 million Full year 2025, up 91% YoY

Billed enrolled employees 22,515 As of Dec 31, 2025, up 23% YoY

Distribution partners 858 Brokers, TPAs and agencies as of Dec 31, 2025, up 34% YoY

2026 revenue outlook $45–$50 million Full-year 2026 guidance, YoY growth 35%–50%

Previous Earnings Reports

4 past events · Latest: Nov 10 (Positive)

Same Type Pattern 4 events

Date	Event	Sentiment	24h Move	Catalyst
Nov 10	Q3 2025 results	Positive	-26.4%	Strong Q3 2025 revenue and EBITDA growth with higher profitability.
Jul 21	Q2 2025 results	Positive	+25.2%	Q2 2025 revenues up 86% YoY with higher Adjusted EBITDA and cash.
Apr 14	Q1 2025 results	Positive	+1.9%	Q1 2025 revenue up 56% YoY and margin expansion before taxes.
Mar 17	FY 2024 results	Negative	-18.3%	Mixed 2024 metrics with flat growth and declines in clients and employees.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings releases have produced volatile reactions, with an average move of -4.38% and one major selloff on strong Q3 2025 results, alongside positive responses to other strong quarters.

Recent Company History

Over 2024–2025, HIT’s earnings reports showed rapid revenue and Adjusted EBITDA growth, with Q1–Q3 2025 results highlighting accelerating scale and expanding cash balances. Full-year 2024 results were more mixed, with modest revenue growth but declining clients and employees. Against this backdrop, today’s full-year 2025 and Q4 2025 results, plus 2026 revenue guidance, extend the narrative of rapid top-line expansion and platform scaling.

Key Terms

adjusted ebitda, non-gaap, gaap, stop-loss, +1 more

5 terms

adjusted ebitda financial

"Full year 2025 Adjusted EBITDA of $4.1 million, up 81% YoY"

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

non-gaap financial

"This release presents Adjusted EBITDA, a non-GAAP financial metric, which is"

Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.

View in glossary

gaap financial

"provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP")."

GAAP, or Generally Accepted Accounting Principles, are a set of standardized rules and guidelines that companies follow when preparing their financial statements. They ensure consistency, transparency, and comparability across different companies, making it easier for investors to understand and compare financial information accurately. This helps investors make informed decisions based on trustworthy and uniform financial reports.

View in glossary

stop-loss financial

"offer more than 100 pre-configured, customized stop-loss programs tailored at the broker-agency level."

A stop-loss is an instruction an investor gives to sell a stock or other asset automatically if its price falls to a specific level, designed to limit how much money they can lose on that position. It matters because it helps manage risk like a safety net or seatbelt—locking in a maximum acceptable loss without needing to watch the market constantly, which can protect a portfolio from sudden drops.

forward‑looking statements regulatory

"Use of Forward‑Looking StatementsCertain statements in this press release are forward-looking statements"

Forward-looking statements are predictions, plans, projections or expectations about a company’s future results, strategy, or events that appear in press releases and regulatory filings. They matter to investors because they are not guarantees and often rely on assumptions that may prove wrong; think of them like a weather forecast useful for planning but uncertain, so investors should weigh those statements against hard facts, past performance and disclosed risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• Full year 2025 Revenues of $33.3 million, up 71% YoY
• Full year 2025 Adjusted EBITDA of $4.1 million, up 81% YoY

STUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or "Company"), an AI-enabled InsurTech platform company, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Financial Highlights for the Full Year 2025 and Fourth Quarter of 2025:

• Revenues. Full year 2025 revenues were $33.3 million, up 71% year over year ("YoY"). Q4 revenues were $7.5 million, up 53% YoY.
• Adjusted EBITDA. Full year 2025 Adjusted EBITDA was $4.1 million, up 81% YoY, Q4 Adjusted EBITDA of $0.3 million compared to prior year Q4 Adjusted EBITDA of $0.5 million.
• Net Income. Full year 2025 net income was $1.3 million, up 91% YoY, Q4 net loss of $0.3 million compared to prior year Q4 net loss of $0.1 million.
• Billed Enrolled Employees. The number of billed enrolled employees (EEs) was 22,515 as of December 31, 2025, up 23% YoY.
• Distribution. The number of Brokers, Third-party Administrator ("TPAs") and Agencies expanded to 858 partners as of December 31, 2025, up 34% YoY.
• Cash. Cash balance was $7.7 million as of December 31, 2025.

Revenue Outlook

Health In Tech expects full-year 2026 revenue to be in the range of $45 million to $50 million, representing year-over-year growth of approximately 35% to 50%. This outlook is based on management's current expectations and assumptions, including continued strong demand for the Company's AI-enabled underwriting marketplace across the self-funded health insurance segment and successful deployment of new features. Actual results may differ materially due to risks and uncertainties described in Health In Tech's filings with the SEC.

The Company expects continued growth driven by expanding engagement across its distribution network and the full deployment of new features launched in January 2026. Unlike the traditional insurance industry, where new product and service implementations typically require one to two years, Health In Tech's AI-driven platform enables new capabilities to be developed and deployed within approximately one to two quarters. This accelerated development cycle provides a meaningful competitive advantage, allowing the Company to respond quickly to broker and client demand, continuously enhance its marketplace offerings, and scale its technology platform more efficiently than traditional market participants.

CEO Commentary 

Tim Johnson, Chief Executive Officer of Health In Tech, commented, "2025 was a defining year of disciplined execution and measurable platform scale for Health In Tech. We strengthened our AI-enabled underwriting marketplace, expanded carrier, broker, and TPA integrations, and further automated core insurance workflows to drive efficiency and margin scalability. We extended underwriting capabilities into larger employer segments and continued enhancing our technology architecture to support enterprise-level throughput across the approximately $300 billion U.S. claims administration market. Most importantly, we translated operational progress into financial performance, delivering 71% year-over-year revenue growth."

Mr. Johnson continued, "As we enter 2026, our focus is on advancing a fully integrated marketplace model that expands beyond underwriting to include additional services such as claims administration and administrative cost-containment solutions. Building on years of assembling specialized healthcare vendors and service providers essential to self-funded plans, we enhanced our platform in January 2026 to offer more than 100 pre-configured, customized stop-loss programs tailored at the broker-agency level. This structured program architecture enables agencies to align standardized offerings with target employer segments, empowering brokers to deliver execution-ready solutions with greater speed, consistency, and operational efficiency. The result is shorter sales cycles, improved conversion visibility, and scalable distribution leverage, while maintaining the flexibility to customize for employer-specific needs.

"In the first half of 2026, we expect to complete market testing of our Three-Year Rate stabilization program, designed to provide cost stability and predictability for eligible employer groups. We also plan to initiate beta testing of a new data-driven solution that integrates physiological data and claims data to generate actionable value insights. Together, these initiatives reflect our strategy of layering incremental, high-value services onto an already commercialized and scalable platform to drive durable growth and increasing operating leverage."

Key Developments in Q1 2026

• Engaged Amazon Web Services (AWS) Advanced Tier Services Partner Ciklum to accelerate development of Health In Tech's AI-Driven InsurTech platform.

• Appointed former SAP and IBM executive Sri Rajagopalan as Chief Technology Officer to advance AI-driven Enterprise-Grade platform growth.

• Appointed five-time founder Zain Hasan as Chief Growth Officer to accelerate revenue growth and scale distribution.

• Introduced 100+ pre-configured stop-loss self-funded healthcare plans for employers, streamlining the renewal process and reducing cycle times.

• Hosted the inaugural independent hitDavos InsurTech Summit during World Economic Forum Week 2026, driving brand visibility and global leadership engagement across the government, technology, healthcare, and finance sectors.

Conference Call Details

Health In Tech will host a conference call to discuss the financial results for the fourth quarter and full year of 2025 on March 25, 2026, at 5:00 p.m. (ET). To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants).

A live audio webcast will be available via the Investor Relations page of Health In Tech's website at https://healthintech.com/. A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

Non-GAAP Financial Information

This release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). Management uses Adjusted EBITDA to provide investors with additional insight into operational performance and to facilitate comparison with other companies in the industry. Adjusted EBITDA should not be considered an alternative to net income, operating income, or other GAAP measures. A reconciliation of historical non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

Use of Forward‑Looking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.

About Health In Tech 

Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration. Learn more at healthintech.com.

 

Health In Tech, Inc.
Consolidated Statements of Operations
		Three Months Ended December 31,				Fiscal Year Ended December 31,
		2025		2024		2025		2024
Revenues
Revenues from underwriting modeling      (ICE)		$1,032,381		$1,697,080		$6,864,545		$6,649,271
Revenues from fees		6,476,204		3,207,484		26,462,966		12,841,635
SMR		6,476,204		2,470,284		26,462,966		9,849,300
HI Card		-		737,200		-		2,992,335
Total revenues		7,508,585		4,904,564		33,327,511		19,490,906
Cost of revenues		3,379,942		1,107,173		12,389,783		4,051,439
Gross profit		4,128,643		3,797,391		20,937,728		15,439,467
Operating expenses
Sales and marketing expenses		906,206		632,060		4,185,766		3,158,257
General and administrative expenses		3,180,137		2,848,014		13,654,262		8,477,407
Research and development expenses		213,113		633,653		1,569,262		2,813,899
Total operating expenses		4,299,456		4,113,727		19,409,290		14,449,563
Other income (expense):
Interest income		104,659		28,774		409,922		122,885
Interest expenses		-		-		-		(495,000)
Other income		-		114,055		118,399		271,211
Other expense		(377,587)		62,759		(382,587)		-
Total other income (expense), net		(272,928)		205,588		145,734		(100,904)
Income (loss) before income tax      expense		$(443,741)		$(110,748)		$1,674,172		$889,000
Provision for income taxes		141,184		(33,404)		(395,330)		(218,523)
Net income (loss)		$(302,557)		$(144,152)		$1,278,842		$670,477
Net income per share
Basic		$(0.01)		$(0.00)		$0.02		$0.01
Diluted		$(0.01)		$(0.00)		$0.02		$0.01
Weighted average common stocks      outstanding
Basic		56,908,999		52,047,723		55,843,821		51,839,329
Diluted		58,635,562		54,662,931		57,742,798		53,662,677

 

 

Health In Tech, Inc.
Consolidated Balance Sheets
		December 31, 2025		December 31, 2024
Assets
Current assets
Cash and cash equivalents		$7,669,754		$7,849,248
Accounts receivable, net		756,288		1,647,103
Loans receivable, net		815,995		-
Other receivables, net		3,467,814		500,252
Deferred offering costs		170,977		-
Prepaid expenses and other current assets		3,280,148		787,161
Total current assets		16,160,976		10,783,764
Non-current assets
Software		6,530,894		3,962,461
Loans receivable, net		-		815,995
Operating lease - right of use assets		139,940		206,269
Long-term prepaid expenses		258,151		-
Total non-current assets		6,928,985		4,984,725
Total assets		$23,089,961		$15,768,489
Liabilities and stockholders' equity
Current liabilities
Accounts payable and accrued expenses		$4,188,811		$1,858,840
Income taxes payable		-		205,253
Operating lease liabilities - current		76,195		66,881
Other current liability		891,598		-
Total current liabilities		5,156,604		2,130,974
Non-current liabilities
Deferred tax liabilities		757,675		328,676
Operating lease liabilities - non-current		63,617		139,811
Total non-current liabilities		821,292		468,487
Total liabilities		5,977,896		2,599,461
Stockholders' equity
Common stock, $0.001 par value; Class A Common    stock 150,000,000 shares authorized 46,006,000 and    42,914,870 shares issued and outstanding as of    December 31, 2025 and December 31, 2024,    respectively		46,006		42,915
Common stock, $0.001 par value; Class B Common    stock 50,000,000 shares authorized, 11,700,000    shares issued and outstanding as of December 31,    2025 and December 31, 2024, respectively		11,700		11,700
Additional paid-in capital		11,834,121		9,173,017
Retained earnings		5,220,238		3,941,396
Total stockholders' equity		17,112,065		13,169,028
Total liabilities and stockholders' equity		$23,089,961		$15,768,489

 

 

Health In Tech, Inc.
Consolidated Statements of Cash Flows
		Fiscal Year Ended December 31,
		2025		2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		$1,278,842		$670,477
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Bad debt expense (recovery)		(16,234)		1,878
Amortization expense		900,577		541,141
Provision for refund liability		3,891,598		-
Provision for credit losses on other receivables		377,587		-
Deferred tax expenses (benefits)		428,999		(93,304)
Amortization of debt discount		-		495,000
Interest income		(64,000)		(63,996)
Stock-based compensation expense		1,570,419		468,489
Changes in operating assets and liabilities:
Accounts receivable		907,049		586,685
Other receivables		(3,345,149)		1,180,848
Prepaid expenses and other assets		(1,948,184)		(514,242)
Operating lease right of use assets and liabilities, net		(551)		1,889
Accounts payable and accrued expenses		2,358,113		(851,963)
Income taxes payable		(205,253)		(246,693)
Other current liabilities		(3,000,000)		-
Net cash provided by operating activities		3,133,813		2,176,209
CASH FLOWS FROM INVESTING ACTIVITIES:
Development of software		(3,189,921)		(900,755)
Interest received from loans receivable		64,000		64,000
Net cash used in investing activities		(3,125,921)		(836,755)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions		-		8,214,000
Proceeds from stock option exercises		23,430		-
Payments of deferred offering costs		(210,816)		(1,975,556)
Repayments of notes payable		-		(2,145,000)
Net cash provided by (used in) financing activities		(187,386)		4,093,444
Increase (decrease) in cash and cash equivalents		(179,494)		5,432,898
Cash and cash equivalents, beginning of year		7,849,248		2,416,350
Cash and cash equivalents, end of year		7,669,754		7,849,248
Supplemental disclosures of cash flow information:
Cash paid for interest		$-		$-
Cash paid for income taxes		$830,726		$558,521
Summary of noncash investing and financing activities:
Accrued deferred offering costs included in accounts      payable and accrued expenses		$-		$39,839
Accrued development of software included in accounts      payable and accrued expenses		$38,363		$50,000
Reclassification of deferred offering costs to additional paid-      in capital upon initial public offering		$-		$2,277,164
Stock-based compensation capitalized for software      development		$290,726		$-

 

 

Health In Tech, Inc.
Reconciliation of GAAP (Net Income) to Non-GAAP Financial Measure (Adjusted EBITDA)
		Three Months Ended December 31,				Fiscal Year Ended December 31,
		2025		2024		2025		2024
Net income		(302,557)		(144,152)		1,278,842		670,477
Interest (income) expenses		(104,659)		(28,774)		(409,922)		372,115
Amortization expense		410,630		135,983		900,577		541,141
Income tax expense		(141,184)		33,404		395,330		218,523
Stock-based compensation expense		76,733		468,489		1,570,419		468,489
Provision for credit losses on other      receivables		377,587		-		377,587		-
Total net adjustments		619,107		609,102		2,833,991		1,600,268
Adjusted EBITDA		316,550		464,950		4,112,833		2,270,745

   

Investor Contact:
Health In Tech Investor Relations
ir@healthintech.com

The Equity Group
Kalle Ahl, CFA          
T: (303) 953-9878     
kahl@theequitygroup.com

Devin Sullivan, Managing Director
dsullivan@theequitygroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-fourth-quarter-and-full-year-2025-financial-results-302725203.html

SOURCE Health In Tech Inc.

FAQ

What were Health In Tech (HIT) full-year 2025 revenues and growth rate?

Full-year 2025 revenue was $33.3 million, a 71% increase year-over-year. According to the company, growth was driven by expanded broker/TPA distribution and higher platform engagement across self-funded health plans.

What guidance did Health In Tech (HIT) give for full-year 2026 revenue?

Health In Tech expects 2026 revenue of $45–$50 million, implying ~35%–50% growth. According to the company, this outlook assumes continued demand for its AI underwriting marketplace and deployment of new features.

How did Health In Tech (HIT) perform on profitability metrics in 2025?

Adjusted EBITDA for 2025 was $4.1 million, up 81% year-over-year; net income was $1.3 million, up 91%. According to the company, operational efficiencies and platform scale translated into improved margins.

What quarterly weaknesses did Health In Tech (HIT) report in Q4 2025?

Q4 2025 showed a Q4 net loss of $0.3 million and adjusted EBITDA of $0.3 million, below prior-year Q4. According to the company, quarterly timing and investments affected short-term profitability metrics.

How large is Health In Tech’s distribution and customer base as of December 31, 2025?

As of year-end 2025, Health In Tech had 22,515 billed enrolled employees and 858 broker/TPA/agency partners. According to the company, distribution expansion contributed materially to 2025 revenue growth.